Cargando…
Corrigendum: Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis
Autores principales: | Zhang, Fan, Zhang, Yuan, Li, Wen-Fei, Liu, Xu, Guo, Rui, Sun, Ying, Lin, Ai-Hua, Chen, Lei, Ma, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745569/ https://www.ncbi.nlm.nih.gov/pubmed/26855358 http://dx.doi.org/10.1038/srep20748 |
Ejemplares similares
-
Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis
por: Zhang, Fan, et al.
Publicado: (2015) -
Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era
por: Zhang, Lu-Ning, et al.
Publicado: (2015) -
Corrigendum to: The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Publicado: (2021) -
Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Cao, Cai-neng, et al.
Publicado: (2015) -
Corrigendum: Perceptual learning to discriminate the intensity and spatial location of nociceptive stimuli
por: Mancini, Flavia, et al.
Publicado: (2017)